Delayed diagnosis of Brugada syndrome in a patient with aborted sudden cardiac death and initial negative flecainide challenge

A negative flecainide challenge does not rule out Brugada syndrome even in the presence of nonfatal cardiac arrest as the first manifestation of the disease. This should prompt clinicians to ensure long‐term ECG follow‐up and consider repeating a drug test with another sodium channel blocker.

Detalles Bibliográficos
Autores principales: Chauveau, Samuel, Le Vavasseur, Olivier, Chevalier, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715432/
https://www.ncbi.nlm.nih.gov/pubmed/29225848
http://dx.doi.org/10.1002/ccr3.1198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715432/
https://www.ncbi.nlm.nih.gov/pubmed/29225848
http://dx.doi.org/10.1002/ccr3.1198

Ejemplares similares